Tag: Nasdaq:SUPN

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the second quarter of 2025 after the market closes on Tuesday, August 5, 2025.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:SUPN

[Latest] Global Information Services Market Size/Share Worth USD 327.94 Billion by 2034 at a 6.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

Weekly share repurchase program transaction details

Q2 2025 turnover

Tag: Nasdaq:SUPN

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us